Publication at Faculty of Medicine in Pilsen |
2010
Abstract
Systemic chemotherapy plays a major role in the management of patients with small cell lung cancer. In the second-line setting, topotecan showed similar efficacy but better tolerability compared to combination chemotherapy and similar efficacy showed oral and venous formulations.
